OpenBilldrug price receipt

NADAC week of 2026-10-14

CLOMIPHENE CITRATE 50 MG TAB

For 30 tablets

Pharmacies pay

$126.16 filed

30 × $4.20523 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit. No Medicare reference price. Part D: The Part D file flags this drug’s average spending per dosage unit as an outlier, so OpenBill does not use it as a reference price. Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$150.08 estimated

$126.16 + $18.92 (15%) + $5.00 fee per fill = $150.08

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

CLOMIPHENE CITRATE 50 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “clomiphene citrate” and “clomiphene citrtae”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as tablet and its route as oral.

FDA lists 5 labelers (the companies named on the label) for its NDCs, among them Accord Healthcare Inc., RISING PHARMA HOLDINGS, INC. and ANI Pharmaceuticals, Inc.

FDA’s Established Pharmacologic Class for it is Estrogen Agonist/Antagonist.

The NADAC file of 2026-10-14 prices it under 11 NDCs (National Drug Codes); the FDA directory lists 10 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $126.16 for 30 tablets (30 × $4.20523 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 5 labelers

LabelerNDCsPharmacies pay per unit
RISING PHARMA HOLDINGS, INC.3$4.20523 per EA filed
ANI Pharmaceuticals, Inc.2$4.20523 per EA filed
Advagen Pharma Ltd2$4.20523 per EA filed
Cosette Pharmaceuticals NC Laboratories, LLC2$4.20523 per EA filed
Accord Healthcare Inc.1$4.20523 per EA filed
Not listed as a package in the FDA directory1$4.20523 per EA filed
All 11 NDCs, with labeler and price
  • 16729-0723-44 · not listed as a package in the FDA directory · $4.20523 per EA · eff. 2026-09-23 filed
  • 16729-0723-51 · Accord Healthcare Inc. · $4.20523 per EA · eff. 2026-09-23 filed
  • 64980-0690-01 · RISING PHARMA HOLDINGS, INC. · $4.20523 per EA · eff. 2026-09-23 filed
  • 64980-0690-03 · RISING PHARMA HOLDINGS, INC. · $4.20523 per EA · eff. 2026-09-23 filed
  • 64980-0690-90 · RISING PHARMA HOLDINGS, INC. · $4.20523 per EA · eff. 2026-09-23 filed
  • 70954-0825-20 · ANI Pharmaceuticals, Inc. · $4.20523 per EA · eff. 2026-09-23 filed
  • 70954-0825-30 · ANI Pharmaceuticals, Inc. · $4.20523 per EA · eff. 2026-09-23 filed
  • 72888-0213-08 · Advagen Pharma Ltd · $4.20523 per EA · eff. 2026-09-23 filed
  • 72888-0213-58 · Advagen Pharma Ltd · $4.20523 per EA · eff. 2026-09-23 filed
  • 83390-0107-09 · Cosette Pharmaceuticals NC Laboratories, LLC · $4.20523 per EA · eff. 2026-09-23 filed
  • 83390-0107-30 · Cosette Pharmaceuticals NC Laboratories, LLC · $4.20523 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

2 other products in the NADAC file share an FDA nonproprietary name with CLOMIPHENE CITRATE 50 MG TAB.

ProductPharmacies pay per unitMedicare per unit
CLOMID 50 MG TABLET
brand · tablet
$16.74327 per EA filed
eff. 2026-06-12
$6.3951 per EA filed
Part D 2024 average
CLOMIPHENE CITRATE 50 MG TAB this page
generic · tablet
$4.20523 per EA filed
eff. 2026-09-23
We don’t know yet
MILOPHENE 50 MG TAB
generic · tablet
$4.20523 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-06-12, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 11 NDCs’ NADAC prices is $4.20523 per EA filed.

Of the 9 other products in FDA’s Estrogen Agonist/Antagonist class priced per EA, 5 have a higher middle NADAC price and 3 a lower one; 1 has the same. The one in the middle is EVISTA 60 MG TABLET, at $6.34306 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.